Aquestive Therapeutics, Inc. AQST Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s total liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported total liabilities of $175.18M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s total liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s total liabilities increased by 7.4% year-over-year, from $163.16M to $175.18M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total liabilities has grown at a 11.7% compound annual growth rate (CAGR), from $111.38M to $194.09M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.